Chihiro Udagawa   Sherwin Kuah   Tatsunori Shimoi   Ken Kato   Teruhiko Yoshida   Mari Hara Nakano   Arata Shimo   Yasuyuki Kojima   Reiko Yoshie   Koichiro Tsugawa   Taisei Mushiroda   Ern Yu Tan   Hitoshi Zembutsu   
Biological & pharmaceutical bulletin 45(8) 1198-1202 2022年8月 [査読有り]
Trastuzumab (herceptin) is an effective drug for human epidermal growth factor receptor type 2 (HER2)-positive cancer. However, cardiotoxicity remains a serious complication. In our previous genome-wide association study (GWAS), we identified pote...